P
2.03
0.08 (4.10%)
| Penutupan Terdahulu | 1.95 |
| Buka | 2.02 |
| Jumlah Dagangan | 880,157 |
| Purata Dagangan (3B) | 1,135,093 |
| Modal Pasaran | 266,256,832 |
| Harga / Jualan (P/S) | 47.53 |
| Harga / Buku (P/B) | 1.79 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -3,603.30% |
| EPS Cair (TTM) | -1.61 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 146.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 113.31% |
| Nisbah Semasa (MRQ) | 4.78 |
| Aliran Tunai Operasi (OCF TTM) | -104.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -106.25 M |
| Pulangan Atas Aset (ROA TTM) | -40.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -115.21% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Prime Medicine, Inc. | Menurun | Menurun |
AISkor Stockmoo
0.4
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.38 |
|
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 24.17% |
| % Dimiliki oleh Institusi | 56.81% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 12.00 (Chardan Capital, 491.13%) | Beli |
| Median | 8.00 (294.09%) | |
| Rendah | 1.50 (Citigroup, -26.11%) | Pegang |
| Purata | 7.38 (263.55%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 1.45 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 27 May 2025 | 1.50 (-26.11%) | Pegang | 1.27 |
| JMP Securities | 20 May 2025 | 6.00 (195.57%) | Beli | 1.18 |
| Chardan Capital | 19 May 2025 | 12.00 (491.13%) | Beli | 1.34 |
| 20 Mar 2025 | 16.00 (688.18%) | Beli | 2.01 | |
| HC Wainwright & Co. | 19 Mar 2025 | 10.00 (392.61%) | Beli | 2.00 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |